CVS HEALTH CORPORATION (CVS) FY2024 Q1 P&L / Income Statement

CVS HEALTH CORPORATION (CVS) FY2024 Q1 P&L / Income Statement

Income statement for 2024-01-01 through 2024-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

88,437,000,000 US dollars

Total operating costs

86,166,000,000 US dollars

Operating income

2,271,000,000 US dollars

Other income (expense), net (calculated)

negative 691,000,000 US dollars

Income before income tax provision

1,580,000,000 US dollars

Income tax provision

456,000,000 US dollars

Net income

1,124,000,000 US dollars

Health Care Benefits

32,236,000,000 US dollars

Health Services

40,285,000,000 US dollars

Pharmacy & Consumer Wellness

28,725,000,000 US dollars

Cost of products sold

48,073,000,000 US dollars

Health care costs

27,803,000,000 US dollars

Loss on assets held for sale

0 US dollars

Operating expenses

10,290,000,000 US dollars

Revenue before reconciliation (calculated)

101,246,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Intersegment Eliminations

negative 12,924,000,000 US dollars. Reported reconciliation to consolidated revenue.

Corporate/ Other

115,000,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to CVS HEALTH CORPORATION: $1.11 B; to noncontrolling interests: $11.00 M.